Balyasny Asset Management LLC Amgen Inc Call Options Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $2.26 Million - $2.46 Million	7,300 Added 46.2%	23,100 $7.44 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $3.78 Million - $4.6 Million	14,400 Added 1028.57%	15,800 $4.94 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $1.26 Million - $1.53 Million	-4,700 Reduced 77.05%	1,400 $398,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $1.28 Million - $1.44 Million	5,000 Added 454.55%	6,100 $1.76 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $240,515 - $298,606	1,100 New	1,100 $295,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $1.33 Million - $1.48 Million	5,700 New	5,700 $1.39 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $148B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.